Entera Bio Ltd. (ENTX)
NASDAQ: ENTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ENTX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $436.32M
- EPS (TTM)
- -$0.36
- Dividend yield
- None
- 52-week range
- 0.91 – 4.20
- Day range
- 2.45 – 2.58
- Volume / Avg
- 679.46K / 1.81M
- Beta
- —
- Shares outstanding
- 173.83M
- Next earnings
- Nov 13, 2026
52-week range
ENTX stock today
Shares of Entera Bio (ENTX) finished lower on Oct 7 at $2.51, a drop of 0.79% or $0.02 per share, versus the S&P 500's 0.22% decline. Trading was light, with 679.46K shares changing hands, about 37% of the average daily volume. Shares are 40.2% below their 52-week high of $4.20, set on Jul 27, 2026 and 175.8% above the 52-week low of $0.91, in the middle of the past year's range.
ENTX is up 29.4% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 32.8%. Entera Bio has posted a net loss over the last twelve months (EPS of -$0.36), so its P/E ratio is not meaningful. Entera Bio's next earnings report is expected on Nov 13, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Entera Bio
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2018
Earnings
Earnings history- Next report
- Nov 13, 2026
Entera Bio peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TECXTectonic Therapeutic Inc. | 22.71 | +1.34% | $443.97M | vs ENTX |
| AGMBAgomAb Therapeutics NV ADR | 8.80 | -0.45% | $433.38M | vs ENTX |
| EDITEditas Medicine Inc. | 2.75 | +0.73% | $422.35M | vs ENTX |
| EIKNEikon Therapeutics Inc. | 7.54 | +0.40% | $408.40M | vs ENTX |
| ZURAZura Bio Limited Class A | 4.17 | +5.30% | $399.61M | vs ENTX |
| AUTLAutolus Therapeutics plc ADR | 1.81 | +1.12% | $481.75M | vs ENTX |
| ALLOAllogene Therapeutics Inc. | 1.43 | -2.05% | $494.05M | vs ENTX |
| KYTXKyverna Therapeutics Inc. | 6.17 | +0.16% | $381.57M | vs ENTX |
Indexes, lists and sector
Largest Health Care stocks
Entera Bio stock FAQ
What is Entera Bio's stock price today?
ENTX last traded at $2.51 as of Oct 7, 4:00 PM EDT, down 0.79% on the day. Prices are delayed at least 15 minutes.
When is Entera Bio's next earnings date?
Entera Bio is expected to report earnings on Friday, November 13, 2026.
What is the ENTX 52-week high?
The 52-week high for ENTX is $4.20 and the 52-week low is $0.91. The stock is currently 40.2% below its high.